Company Monitoring Page for Allergan

latest headlines for company on cafepharma

Allergan ex-CEO Saunders takes board seat at BridgeBio
Fierce Biotech
Fri, 06/26/20 - 09:54 am
Tags:
Brent Saunders, Pharma CEOs, Allergan, BridgeBio
Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact
Fierce Biotech
Fri, 06/19/20 - 11:24 am
Tags:
Assembly Biosciences, microbiome, Allergan, AbbVie, M&A
Abbvie-Allergan complete, but critics continue to raise anti-competitive concerns
Endpoints
Thu, 06/18/20 - 10:39 am
Tags:
AbbVie, Allergan, M&A, FTC
Breast Implant Makers Land in Hot Water with FDA
Medical Devices and Diagnostics Industry
Thu, 05/14/20 - 10:52 pm
Tags:
FDA, breast implants, devices, Allergan, Ideal Implant
Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray
Endpoints
Mon, 05/11/20 - 10:36 am
Tags:
Oyster Point Pharma, dry eye disease, OC-01, Allergan, Restasis, Shire, Xiidra
AbbVie, Allergan score FTC approval for $63B merger with one final hurdle left to go
Fierce Pharma
Wed, 05/6/20 - 12:09 am
Tags:
AbbVie, Allergan, M&A, FTC
AbbVie CEO: Don't worry, Allergan's aesthetics clients still have money—and 'strong desire' for treatment
Fierce Pharma
Fri, 05/1/20 - 12:57 pm
Tags:
AbbVie, Allergan, M&A, aesthetics, pandemic, COVID-19
A Covid-19 threat to business acquisitions
EP Vantage
Thu, 04/2/20 - 11:57 am
Tags:
COVID-19, M&A, AbbVie, Allergan, Arya Sciences, Immatics, AcelRx, Tetraphase, Gilead Sciences, Forty Seven, Thermo Fisher, Stryker, Wright Medical
AbbVie and Allergan Sign Divestiture Consent Decree with FTC, Move Closer to Finalizing Merger
BioSpace
Thu, 03/19/20 - 12:01 am
Tags:
AbbVie, Allergan, FTC, M&A
AbbVie, Allergan merger may face regulatory delay due to COVID-19: report
Fierce Pharma
Tue, 03/17/20 - 11:32 pm
Tags:
AbbVie, Allergan, FTC, M&A, COVID-19
Amgen/Allergan’s rituximab biosimilar could be $4bn blockbuster
Pharmaforum
Wed, 03/11/20 - 10:45 am
Tags:
Amgen, Allergan, biosimilars, Roche, rituximab
10 Drugs Expected to Enter the Market This Year Could be Blockbusters, Analysis Says
BioSpace
Mon, 03/9/20 - 11:10 pm
Tags:
biosimilars, Amgen, Allergan, Roche, Rituxan, Bristol-Myers Squibb, ozanimod, risdiplam, Biomarin, valrox
FDA approves Allergan’s biodegradable glaucoma implant drug
PM Live
Fri, 03/6/20 - 11:46 pm
Tags:
Allergan, Durysta, FDA, glaucoma
AbbVie and Allergan finally set (rough) date for wedding as one parent agrees to the match
Endpoints
Wed, 03/4/20 - 10:54 am
Tags:
AbbVie, Allergan, M&A
Biohaven scores CGRP OK for acute migraine — can the commercial team catch up with Allergan on its debut?
Endpoints
Thu, 02/27/20 - 11:46 pm
Tags:
Biohaven, FDA, migraines, Nurtec, Allergan, AbbVie, Ubrelvy
Allergan accused of misleading CoolTone marketing in new lawsuit from BTL
Fierce Pharma
Wed, 02/26/20 - 10:31 am
Tags:
Allergan, BTL, CoolTone, devices, EmSculpt
In final report, ICER appears to have a change of heart on new acute migraine therapies
Endpoints
Tue, 02/25/20 - 10:40 am
Tags:
ICER, migraines, Biohaven, Allergan, ubrogepant, rimegepant, Eli Lilly, Lasmiditan
Allergan Sued by BTL Over False Advertising Claims Regarding Muscle-Toning Product
Motley Fool
Sat, 02/22/20 - 11:26 pm
Tags:
Allergan, BTL, advertising
Allergan's Botox still a physician favorite for migraine despite CGRP push: analyst
Fierce Pharma
Fri, 02/21/20 - 10:49 am
Tags:
Allergan, Botox, migraines, physicians, neurologists, CGRPs
Allergan targets filler-prone millennials with new Juvederm lip campaign
Fierce Pharma
Wed, 02/12/20 - 10:48 am
Tags:
Allergan, Juvederm, millennials, DTC ads

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.